Polymerase Chain Reaction companies

  • Report ID: 2327
  • Published Date: Aug 22, 2025
  • Report Format: PDF, PPT

Key Polymerase Chain Reaction Market Players:

    The current dynamics in the polymerase chain reaction market are controlled by the strategic operations of key players, who are increasingly investing in AI-driven automation, precision diagnostics, and sustainable solutions. For instance, Thermo Fisher Scientific and Siemens Healthineers concentrated their focus on constructing a new pipeline with high-efficiency PCR systems. Similarly, QIAGEN and Samsung Healthcare are integrating AI to enhance the accuracy and scalability of this diagnostic discipline. Moreover, the collective effort of these innovators in establishing a strong foundation of R&D in this field is reinforcing technological advancements and efficiency escalation at a global scale.

    Below is the list of some prominent players operating in the global market:

    • Thermo Fisher Scientific
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Bio-Rad Laboratories
    • Agilent Technologies
    • Danaher (Cepheid)
    • Qiagen N.V.
    • Merck KGaA (Sigma-Aldrich)
    • Abbott Laboratories
    • Illumina Inc.
    • Roche Diagnostics
    • PerkinElmer (Revvity)
    • Becton Dickinson (BD)
    • Promega Corporation
    • Takara Bio USA (subsidiary)
    • Beckman Coulter (Danaher)
    • Fluidigm (Standard BioTools)
    • Takara Bio Inc.
    • Shimadzu Corporation
    • Hitachi High-Tech Corp.
    • Eiken Chemical Co. Ltd.
    • Nippon Genetics Co. Ltd.

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

In the year 2026, the industry size of polymerase chain reaction is evaluated at USD 19.4 billion.

Polymerase Chain Reaction Market size was over USD 18.3 billion in 2025 and is poised to exceed USD 33.9 billion by 2035, growing at over 6.7% CAGR during the forecast period i.e., between 2026-2035.

North America industry is expected to hold largest revenue share by 2035, as a result of growing advancements in the healthcare industry in the region.

The major players in the market are Abbott Laboratories, Becton, Dickinson and Company, Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., GE Healthcare, bioMérieux, Siemens Healthcare Private Limited, Merck KGaA, Thermo Fisher Scientific Inc., PerkinElmer Inc., and others.
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos